Care of the Elderly Resources

Search Knowledge Base by Keyword

Session 12: Mood Disorders

Last Updated On
Print
You are here:
< Back
Didactic SlidesDownload
Case RecommendationsDownload

References:

  1. Lozupone M, La Montagna M, D’Urso F, et al. Pharmacotherapy for the treatment of depression in patients with Alzheimer’s disease: a treatment-resistant depressive disorder. Expert Opin Pharmacother. 2018;19(8):823-842. doi:10.1080/14656566.2018.1471136

  2. Reynolds CF 3rd. Depression: making the diagnosis and using SSRIs in the older patient. Geriatrics. 1996;51(10):28-34.

  3. Bartels C, Wagner M, Wolfsgruber S, Ehrenreich H, Schneider A; Alzheimer’s Disease Neuroimaging Initiative. Impact of SSRI Therapy on Risk of Conversion From Mild Cognitive Impairment to Alzheimer’s Dementia in Individuals With Previous Depression. Am J Psychiatry. 2018;175(3):232-241. doi:10.1176/appi.ajp.2017.17040404

  4. Banerjee S, Hellier J, Dewey M, et al. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet. 2011;378(9789):403-411. doi:10.1016/S0140-6736(11)60830-1

  5. Zuidersma M, Chua KC, Hellier J, Voshaar RO, Banerjee S; HTA-SADD Investigator Group. Sertraline and Mirtazapine Versus Placebo in Subgroups of Depression in Dementia: Findings From the HTA-SADD Randomized Controlled Trial. Am J Geriatr Psychiatry. 2019;27(9):920-931. doi:10.1016/j.jagp.2019.03.021

  6. Banerjee S, Hellier J, Romeo R, et al. Study of the use of antidepressants for depression in dementia: the HTA-SADD trial–a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine. Health Technol Assess. 2013;17(7):1-166. doi:10.3310/hta17070

  7. Kessler RC, Birnbaum HG, Shahly V, et al. Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: results from the WHO World Mental Health Survey Initiative. Depress Anxiety. 2010;27(4):351-364. doi:10.1002/da.20634

  8. Kennedy SH, Lam RW, McIntyre RS, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments [published correction appears in Can J Psychiatry. 2017 May;62(5):356]. Can J Psychiatry. 2016;61(9):540-560. doi:10.1177/0706743716659417

  9. van der Veen DC, van Zelst WH, Schoevers RA, Comijs HC, Voshaar RC. Comorbid anxiety disorders in late-life depression: results of a cohort study. Int Psychogeriatr. 2015;27(7):1157-1165. doi:10.1017/S1041610214002312

  10. Tsoi KK, Chan JY, Hirai HW, Wong SY. Comparison of diagnostic performance of Two-Question Screen and 15 depression screening instruments for older adults: systematic review and meta-analysis [published correction appears in Br J Psychiatry. 2017 Aug;211(2):120]. Br J Psychiatry. 2017;210(4):255-260. doi:10.1192/bjp.bp.116.186932

  11. Haigh EAP, Bogucki OE, Sigmon ST, Blazer DG. Depression Among Older Adults: A 20-Year Update on Five Common Myths and Misconceptions. Am J Geriatr Psychiatry. 2018;26(1):107-122. doi:10.1016/j.jagp.2017.06.011

  12. Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry. 2006;63(5):530-538. doi:10.1001/archpsyc.63.5.530

  13. Taylor WD. Clinical practice. Depression in the elderly. N Engl J Med. 2014;371(13):1228-1236. doi:10.1056/NEJMcp1402180

  14. Lyness JM, Caine ED, King DA, Conwell Y, Duberstein PR, Cox C. Depressive disorders and symptoms in older primary care patients: one-year outcomes. Am J Geriatr Psychiatry. 2002;10(3):275-282.

  15. Pimontel MA, Culang-Reinlieb ME, Morimoto SS, Sneed JR. Executive dysfunction and treatment response in late-life depression. Int J Geriatr Psychiatry. 2012;27(9):893-899. doi:10.1002/gps.2808

  16. Cooney GM, Dwan K, Greig CA, et al. Exercise for depression. Cochrane Database Syst Rev. 2013;(9):CD004366. Published 2013 Sep 12. doi:10.1002/14651858.CD004366.pub6

  17. Gallagher D, Mhaolain AN, Greene E, et al. Late life depression: a comparison of risk factors and symptoms according to age of onset in community dwelling older adults. Int J Geriatr Psychiatry. 2010;25(10):981-987. doi:10.1002/gps.2438

  18. Cuijpers P, Karyotaki E, Pot AM, Park M, Reynolds CF 3rd. Managing depression in older age: psychological interventions. Maturitas. 2014;79(2):160-169. doi:10.1016/j.maturitas.2014.05.027

  19. Barnes DE, Yaffe K, Byers AL, McCormick M, Schaefer C, Whitmer RA. Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia. Arch Gen Psychiatry. 2012;69(5):493-498. doi:10.1001/archgenpsychiatry.2011.1481

  20. Aizenstein HJ, Khalaf A, Walker SE, Andreescu C. Magnetic resonance imaging predictors of treatment response in late-life depression. J Geriatr Psychiatry Neurol. 2014;27(1):24-32. doi:10.1177/0891988713516541

  21. Hegeman JM, Kok RM, van der Mast RC, Giltay EJ. Phenomenology of depression in older compared with younger adults: meta-analysis. Br J Psychiatry. 2012;200(4):275-281. doi:10.1192/bjp.bp.111.095950

  22. Vlainić JV, Šuran J, Vlainić T, Vukorep AL. Probiotics as an Adjuvant Therapy in Major Depressive Disorder. Curr Neuropharmacol. 2016;14(8):952-958. doi:10.2174/1570159×14666160526120928

  23. Steffens DC, Taylor WD, Krishnan KR. Progression of subcortical ischemic disease from vascular depression to vascular dementia. Am J Psychiatry. 2003;160(10):1751-1756. doi:10.1176/appi.ajp.160.10.1751

  24. Olin JT, Schneider LS, Katz IR, et al. Provisional diagnostic criteria for depression of Alzheimer disease. Am J Geriatr Psychiatry. 2002;10(2):125-128.

  25. Zhang X, Norton J, Carrière I, Ritchie K, Chaudieu I, Ancelin ML. Risk factors for late-onset generalized anxiety disorder: results from a 12-year prospective cohort (the ESPRIT study). Transl Psychiatry. 2015;5(3):e536. Published 2015 Mar 31. doi:10.1038/tp.2015.31

  26. Bature F, Guinn BA, Pang D, Pappas Y. Signs and symptoms preceding the diagnosis of Alzheimer’s disease: a systematic scoping review of literature from 1937 to 2016. BMJ Open. 2017;7(8):e015746. Published 2017 Aug 28. doi:10.1136/bmjopen-2016-015746

  27. Melo A, Kokras N, Dalla C, et al. The positive effect on ketamine as a priming adjuvant in antidepressant treatment. Transl Psychiatry. 2015;5(5):e573. Published 2015 May 26. doi:10.1038/tp.2015.66

  28. Licht-Strunk E, van der Windt DA, van Marwijk HW, de Haan M, Beekman AT. The prognosis of depression in older patients in general practice and the community. A systematic review. Fam Pract. 2007;24(2):168-180. doi:10.1093/fampra/cml071

Sertraline-and-Mirtazapine-Versus-Placebo-in-Subgroups-of-Depression-in-DementiaDownload
Impact-of-SSRI-Therapy-on-Risk-of-Conversion-From-Mild-Cognitive-Impairment-to-Alzheimers-Dementia-in-Individuals-With-Previous-DepressionDownload
Download